The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters
These details determine whether you get the potency you paid for
Results compound over the full 3-month cycle, so the biggest changes come to those who stay consistent through to the end
For patients with these conditions, a maintenance schedule of injections every one to three months is typical after getting their levels back up
Our treatments provide a fast-acting energy boost, improved mood, and support for the nervous and immune systems